Sun Pharma Beats Analysts Expectation with 28% YoY Increase in Net Profit!


  • Profit Growth: Sun Pharma reported a 28% year-over-year increase in net profit, reaching ₹3,040 crore, surpassing analyst expectations.
  • Revenue Increase: Total revenue rose 11.3% YoY to ₹12,192 crore, driven by strong performance across domestic and international markets.
  • India Sales: Sales in India grew 11.1% YoY, contributing to 32% of total revenue.
  • US Market: US sales also saw a 4.2% increase, accounting for over 30% of the company’s revenue.
  • R&D Investment: Sun Pharma boosted its R&D expenditure to ₹773 crore, focusing on specialty and generics.

Comments

Popular posts from this blog

Sky High Surge: IndiGo Soars as India’s Air Passenger Traffic Climbs 8.4% in April

RBI’s Record Dividend Bonanza: Government’s Coffers Swell by Rs 2.69 Lakh Crore for FY 2024-25

IndiGo Set to Make History: First to Soar from Navi Mumbai Airport with 18 Daily Flights!